조산 진단 검사 키트 시장 규모, 점유율, 성장 분석 : 검사 유형별, 검체 유형별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Preterm Birth Diagnostic Test Kits Market size was valued at USD 163.77 Million in 2024 and is poised to grow from USD 176.21 Million in 2025 to USD 316.62 Million by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The market for Preterm Birth Diagnostic Test Kits is experiencing significant growth, propelled by the increasing incidence of preterm births and the urgent need for early detection methods. These kits utilize biomarker analysis and clinical indicators for efficient risk assessment, backed by heightened awareness among healthcare professionals and expectant mothers. Advancements in diagnostic technology further drive this market, with North America and Europe commanding substantial shares due to their advanced healthcare systems. Meanwhile, the Asia-Pacific region showcases promising potential, spurred by rising healthcare investments and awareness levels. A notable trend is the shift toward point-of-care testing, which allows for immediate assessments and timely healthcare interventions, particularly beneficial in areas with limited access to sophisticated medical facilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Preterm Birth Diagnostic Test Kits market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Preterm Birth Diagnostic Test Kits Market Segments Analysis

Global Preterm Birth Diagnostic Test Kits Market is segmented by Test Type, Sample Type, End User and region. Based on Test Type, the market is segmented into Fetal Fibronectin (fFN) Test Kits, Placental Alpha Microglobulin-1 (PAMG-1) Test Kits and Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits. Based on Sample Type, the market is segmented into Blood Sample, Urine Sample and Vaginal Discharge Sample. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Preterm Birth Diagnostic Test Kits Market

The rising prevalence of preterm births, characterized by delivery before 37 weeks of pregnancy, presents a critical public health challenge worldwide. This growing trend fuels the need for precise and dependable diagnostic test kits aimed at identifying and forecasting preterm labor. The focus on enhancing maternal and neonatal health outcomes, along with the efforts of healthcare providers and policymakers to mitigate preterm birth rates, ensures a sustained demand for these essential diagnostic tools. As awareness of the implications of preterm birth continues to grow, the market for these test kits is expected to expand further.

Restraints in the Preterm Birth Diagnostic Test Kits Market

The preterm birth diagnostic test kits market faces significant challenges due to the stringent regulations governing the medical diagnostic industry, which are in place to safeguard patient safety and ensure product effectiveness. The process of developing and bringing new diagnostic test kits to market, particularly those focused on pregnancy and neonatal health, involves extensive testing and approval requirements. These regulatory obstacles can hinder the timely launch of innovative test kits, ultimately affecting their market availability and the rate at which they are adopted by healthcare providers and patients alike.

Market Trends of the Preterm Birth Diagnostic Test Kits Market

The preterm birth diagnostic test kits market is experiencing a significant trend driven by advancements in diagnostic technologies. Innovations are leading to the creation of more accurate and reliable testing options that empower healthcare professionals to predict preterm birth risk with enhanced precision. This market evolution encompasses the integration of diverse biomarkers, genetic testing, and proteomics, alongside other cutting-edge methodologies, which collectively improve the sensitivity and specificity of the diagnostic tests. As a result, the focus on personalized maternal care and early intervention strategies is intensifying, positioning these test kits as crucial tools in improving pregnancy outcomes and reducing preterm birth rates.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Preterm Birth Diagnostic Test Kits Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Fetal Fibronectin (fFN) Test Kits
• Placental Alpha Microglobulin-1 (PAMG-1) Test Kits
• Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1) Test Kits

Global Preterm Birth Diagnostic Test Kits Market Size by Sample Type & CAGR (2026-2033)

• Market Overview
• Blood Sample
• Urine Sample
• Vaginal Discharge Sample

Global Preterm Birth Diagnostic Test Kits Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Specialty Clinics

Global Preterm Birth Diagnostic Test Kits Market Size & CAGR (2026-2033)

• North America (Test Type, Sample Type, End User)
  • US
  • Canada
• Europe (Test Type, Sample Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Sample Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Sample Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Sample Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenMark Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoString Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Myriad Genetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations